Pneumonia

 Jordi Rello. Tarragona, Spain.

 

 Aims & Missions

The working group on Pneumonia was established to initiate collaborative research covering topics in pneumonia relevant to critically ill patients. Primary interest are VAP and sCAP. Secondary interests are VAT, AECB in COPD patients, HAP and HCAP requiring ICU admission.

Specific aims are diagnosis, therapy, and prevention. Active members of the working group serve as a basis to provide excellence investigator sites for conducting phase II and III RCT on respiratory infections.

Two members of the Working Group have participated in a multidisciplinary panel of experts designing a consensus document on care bundles for prevention and management of VAP in Europe. Further projects validating these european care bundles by the members of the Working Group and other projects of  VAP prevention are planned.

The EUVAP project is endorsed by the ECCRN and have recruited near 3,000 patients in 27 european ICUs. After analysis of the database will provide a first picture on the spectrum of diagnosis, organisms and antibiotic use in a selected group of european ICUs. Once, analyzed, a second EUVAP project involving new investigators site will be launched.

The CAPUCI2 study has three primary objectives: 1) To enroll (immunocompetent and immunocompromised) patients with pneumococcal pneumonia  in European ICUs. 2) To enroll patients with non-pneumococcal CAP. 3) To assess why antibiotics and organ failure support measures are not enough in patients with sCAP.  The study will be submitted for ECCRN endorsement and is planned to start recruitment in late 2008.

 

Minutes of the meeting held in Lisbon on the 23rd September 2008.

Minutes of the meeting held in Brussels on the 26th March 2009.

 

 

INF Section